Journal of Endocrinological Investigation

, Volume 20, Issue 3, pp 158–167 | Cite as

Human endometrium as a neuroendocrine tissue: Expression, regulation and biological roles of endometrial corticotropin-releasing hormone (CRH) and opioid peptides

  • E. Zoumakis
  • A. N. Margioris
  • A. Makrigiannakis
  • C. Stournaras
  • A. Gravanis
Review Article


endometrium opioids CRH implantation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Vale W., Spiess J., Rivter C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213: 1394, 1981.PubMedCrossRefGoogle Scholar
  2. 2.
    Vale W., Rivier C, Brown M.R., Spiess J., Koob G., Swanson A. Chemical and biological characterization of corticotropin-releasing factor. Recent Prog. Horm. Res. 39: 245, 1983.PubMedGoogle Scholar
  3. 3.
    Antoni F.A. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr. Rev. 7: 351, 1986.PubMedCrossRefGoogle Scholar
  4. 4.
    Orth D. Corticotropin-releasing hormone in humans. Endocr. Rev. 13: 164, 1992.PubMedGoogle Scholar
  5. 5.
    Usui T., Nakai Y., Tsukada T., Jingami H., Takahashi H., Fucada J. Expression of adrenocorticotropin-releasing hormone precursor gene in placenta and other nonhypothalamic tissues in man. Mol. Endocrinol. 2: 871, 1988.PubMedCrossRefGoogle Scholar
  6. 6.
    Suda T., Tomori N., Tozawa F., Mouri T., Demoura H., Shizume K. Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues. J. Clin. Endocrinol. Metab. 59: 861, 1984.PubMedCrossRefGoogle Scholar
  7. 7.
    Petrusz P., Merghenthaler I., Maderdrut L., Vigh S., Schally A. Corticotropin-releasing factor-like immunoreactivity in the vertebrate endocrine pancreas. Proc. Natl. Acad. Sci. 80: 1721, 1983.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Petrusz P., Merghenthaler I., Ordronneau P., Maderdrut L., Vigh S., Schally A. Corticotropin-releasing factor-like immunoreactivity in the gastro-entero-pancreatic endocrine system. Peptides 5: 71, 1984.PubMedCrossRefGoogle Scholar
  9. 9.
    Dammrich J., Ormanns W., Kahaly G., Schrezenmeir J. Multiple peptide hormone producing adenocarcinoma of lung with neurotensin and CRF-like immunoreactivity. Pathol. Res. Pract. 183: 670, 1988.PubMedCrossRefGoogle Scholar
  10. 10.
    Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43: 425, 1991.PubMedGoogle Scholar
  11. 11.
    Donaldson C.J., Sutton S.W., Perrin M.H., Corrigan A.Z., Lewis K.A., Rivier J.E., Vaughan J.M., Vale W.W. Cloning and characterization of human urocortin. Endocrinology 137: 2167, 1996.PubMedCrossRefGoogle Scholar
  12. 12.
    Ross P.C., Kostas CM., Ramabhadran T.V. A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology. Biochem. Biophys. Res. Comun. 205: 1836, 1994.CrossRefGoogle Scholar
  13. 13.
    Hillhouse E.W., Grammatopoulos D., Milton N.G., Quartero H.W. The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy. J. Clin. Endocrinol. Metab. 76: 736, 1993.PubMedGoogle Scholar
  14. 14.
    Smets G., Van-Gompel J., Meyer C, Abs R., de Menten Y., Kloppel G. Corticotropin-releasing hormone receptors on human pituitary cells: autoradiography at the light microscopical level, quantification and immunocyto-chemistry. Prog. Histochem. Cytochem. 26: 107, 1992.PubMedCrossRefGoogle Scholar
  15. 15.
    Polymeropoulos M.H., Torres R., Yanovski J.A., Chandrasekharappa S.C., Ledbetter D.H. The human corticotropin-releasing factor receptor (CRHR) gene maps to chromosome 17q12-q22. Genomics 28: 123, 1995.PubMedCrossRefGoogle Scholar
  16. 16.
    Xiong Y., Xie L.Y., Abou-Samra A.B. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor. Endocrinology 136: 1828, 1995.PubMedGoogle Scholar
  17. 17.
    Perrin M., Donaldson C, Chen R., Blount A., Berggren T., Bilezikjian L., Sawchenko P., Vale W. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. 92: 2969, 1995.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Kishimoto T., Pearse R.V. 2nd, Lin C.R., Rosenfeld M.G. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. USA 92: 1108, 1995.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA 92: 836, 1995.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Grigoriadis D.E., Heroux J.A., De Souza E.B. Characterization and regulation of corticotropin-releasing factor receptors in the central nervous, endocrine and immune systems. Ciba Found. Symp. 172: 85, discussion 101–7, 1993.PubMedGoogle Scholar
  21. 21.
    Chang CP., Pearse R.V. 2d, O’Connell S., Rosenfeld M.G. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron. 11: 1187, 1993.PubMedCrossRefGoogle Scholar
  22. 22.
    Chen R., Lewis K.A., Perrin M.H., Vale W.W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl. Acad. Sci. 90: 8967, 1993.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Hughes J. Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res. 88: 295, 1975.PubMedCrossRefGoogle Scholar
  24. 24.
    Hughes J., Smith T.W., Kosterlitz H.G., Fothergill L.A., Morgan B.A., Morris H.R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258: 577, 1975.PubMedCrossRefGoogle Scholar
  25. 25.
    Lynch D.R., Snyder S.H. Neuropeptides: Multiple molecular forms, metabolic pathways and receptors. Ann. Rev. Biochem. 55: 773, 1986.PubMedCrossRefGoogle Scholar
  26. 26.
    Lord J.A.H., Waterfield A.A., Hughes J., Kosterlitz H.W. Endogenous opioid peptides:multiple agonists and receptors. Nature 267: 495, 1977.PubMedCrossRefGoogle Scholar
  27. 27.
    Numa S. Opioid peptide precursors and their genes. In: Gross E., Meienhofer J. (Eds.), The peptides. Academic Press, New York, 1984, vol. 6, p. 1.Google Scholar
  28. 28.
    Chavkin C, Goldstein A. Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus. Nature 297: 591, 1981.CrossRefGoogle Scholar
  29. 29.
    Shultz R., Wüster M., Herz A. Endogenous ligands for k-opiate receptors. Peptides 3: 973, 1982.CrossRefGoogle Scholar
  30. 30.
    Chavkin C, James J., Goldstein A. Dynorphin is a specific endogenous ligand of kappa opioid receptor. Science 275: 413, 1982.CrossRefGoogle Scholar
  31. 31.
    Atweh S.F, Kuhar M.J. Distribution and significance of opioid receptors in the brain. Br. Med. Bull. 39: 47, 1983.PubMedGoogle Scholar
  32. 32.
    Atweh S.F., Kuhar M.J. Autoradiographic localization of opiate receptors in rat brain spinal cord and lower medulla. Brain Res. 124: 53, 1977.PubMedCrossRefGoogle Scholar
  33. 33.
    Atweh S.R, Kuhar M.J. Autoradiographic localization of opiate receptors in rat brain stem II. The brain stem. Brain Res. 129: 1, 1977.PubMedCrossRefGoogle Scholar
  34. 34.
    Atweh S.F., Kuhar M.J. Autoradiographic localization of opiate receptors in rat brain III. The telencephalon. Brain Res. 134: 393, 1977.PubMedCrossRefGoogle Scholar
  35. 35.
    Wüster M., Schultz R., Herz A. Multiple opiate receptors in peripheral tissue preparations. Biochem Pharmacol. 30: 1883, 1981.PubMedCrossRefGoogle Scholar
  36. 36.
    Yoon D.J., Sklar C., David R. Presence of immunoreactive corticotropin-releasing factor in rat testis. Endocrinology 122: 759, 1988.PubMedCrossRefGoogle Scholar
  37. 37.
    Audhya T., Hollander C.S., Schlesinger D.H., Hutchinson B. Structural characterization and localization of corticotropin-releasing factor in testis. Biochim. Biophys. Acta 995: 10, 1989.PubMedCrossRefGoogle Scholar
  38. 38.
    Fabbri A., Tinajero J.C, Dufau M.L. Corticotropin-releasing factor is produced by rat Leydig cells and has a major local antireproductive role in the testis. Endocrinology 127: 1541, 1990.PubMedCrossRefGoogle Scholar
  39. 39.
    Dufau M.L, Tinajero J.C, Fabbri A. Corticotropin-releasing factor: an antireproductive hormone of the testis. FASEB J 7: 299, 1993.PubMedGoogle Scholar
  40. 40.
    Huang B.M., Stocco D.M., Hutson J.C., Norman R.L. Corticotropin-releasing hormone stimulates steroidogenesis in mouse Leydig cells. Biol. Reprod. 53: 620, 1995.PubMedCrossRefGoogle Scholar
  41. 41.
    Mastorakos G., Webster E., Friedman T., Chrousos G. Immunoreactive corticotropin-releasing hormone and its binding in the rat ovaries. J. Clin. Invest 92: 961, 1993.PubMedCentralPubMedCrossRefGoogle Scholar
  42. 42.
    Mastorakos G., Scopa C., Vryonidou A., Friedman T., Kattis D., Phenekos C, Merino M., Chrousos G. Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries. J. Clin. Endocrinol. Metab. 79: 1191, 1994.PubMedGoogle Scholar
  43. 43.
    Grino M., Chrousos G., Margioris A. The corticotropin-releasing hormone gene is expressed in human placenta. Biochem. Biophys. Res. Commn. 148: 1208, 1987.CrossRefGoogle Scholar
  44. 44.
    Margioris A.N. Corticotropin releasing hormone and the placenta and fetal membranes. In: Brennecke S., Rice G. (Eds.), Molecular aspects of placental and fetal membrane autacoids. CRC Press (publs) 1993, vol 12, p. 277.Google Scholar
  45. 45.
    Linton E.A., Perkins A.V., Woods R.J., Eben F., Wolfe CD., Behan D.P., Potter E., Vale W.W., Lowry P.J. Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy. J. Clin. Endocrinol. Metab. 76: 260, 1993.PubMedGoogle Scholar
  46. 46.
    Campbell E.A., Linton E.A., Wolfe CD., Scraggs P.P., Jones M.T., Lowry P.J. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J. Clin. Endocrinol. Metab. 64: 1054, 1987.PubMedCrossRefGoogle Scholar
  47. 47.
    Frim D., Emanuel P., Robinson B., Smas C., Adler G., Majzoub J. Characterization and gestational regulation of corticotropin-releasing hormone mRNA in human placenta. J. Clin. Invest. 82: 287, 1988.PubMedCentralPubMedCrossRefGoogle Scholar
  48. 48.
    Petraglia F., Sawchenko P.E., Rivier J., Vale W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 328: 717, 1987.PubMedCrossRefGoogle Scholar
  49. 49.
    Robinson B., Emanuel R., Frim D., Majzoub J. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc. Natl. Acad. Sci. 85: 5244, 1988.PubMedCentralPubMedCrossRefGoogle Scholar
  50. 50.
    Margioris A.N., Grino M., Protos P., Gold P., Chrousos G. Corticotropin-releasing hormone and oxytocin stimulate the release of placental proopiomelanocortin peptides. J. Clin. Endocrinol. Metab. 66: 922, 1988.PubMedCrossRefGoogle Scholar
  51. 51.
    Petraglia F., Potter E., Cameron V.A., Sutton S., Behan D.P., Woods R.J., Sawchenko P.E., Lowry P.J., Vale W. Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J. Clin. Endocrinol. Metab. 77: 919, 1993.PubMedGoogle Scholar
  52. 52.
    Coukos G., Monzani A., Saletti C, Petraglia F. Noradrenaline and interleukin-1 stimulate CRF secretion from human placental cells in culture. Medicina 8: 441, 1988.PubMedGoogle Scholar
  53. 53.
    Margioris A.N., Grino M., Rabin D., Chrousos G.P. Human placenta and the hypothalamic-pituitary-adrenal axis. Adv. Exp. Med. Biol. 245: 389, 1988.PubMedCrossRefGoogle Scholar
  54. 54.
    Hatzoglou A., Margioris A.N., Bakogeorgou E., Gravanis A., Castanas E. Identification, characterization and localization of corticotropin-releasing hormone receptors in human placenta. Life Sci. 59: 1871, 1996.PubMedCrossRefGoogle Scholar
  55. 55.
    Quartero H.W., Fry CH. Placental corticotrophin releasing factor may modulate human parturition. Placenta 10: 439, 1989.PubMedCrossRefGoogle Scholar
  56. 56.
    Sasaki A., Tempst P., Liotta A.S., Margioris A.N., Hood L.E., Kent S.B., Sato S., Shinkawa O., Yoshinaga K., Krieger D.T. Isolation and characterization of a corticotropin-re leasing hormone-like peptide from human placenta. J. Clin. Endocrinol. Metab. 67: 768, 1988.PubMedCrossRefGoogle Scholar
  57. 57.
    Cox B., Rosenberg J.G., Douglass J. Chromatographic characterization of dynorphin and (leu5)enkephalin immunoreactivity in guinea pig and rat testis. Regul. Pept. 19: 17, 1987.CrossRefGoogle Scholar
  58. 58.
    Pintar J.E., Schachter B.S., Herman A.B., Durgerian S., Krieger D.T. Characterization and localization of proopiomelanocortin messenger RNA in the adult rat testis. Science 225: 632, 1984.PubMedCrossRefGoogle Scholar
  59. 59.
    Eskeland N.L., Molineaux C.J., Schacter B.S. Regulation of β-endorphin secretion by corticotropin-releasing factor in the intact rat testis. Endocrinology 130: 1173, 1992.PubMedGoogle Scholar
  60. 60.
    Fabri A., Tsai Morris C.H., Luna S., Fraioli F., Dufau M.L. Opiate receptors are present in rat testis. Identification and localization in Sertoli cells. Endocrinology 117: 2544, 1985.CrossRefGoogle Scholar
  61. 61.
    Sharpe P.M., Cooper I. Comparison of the effects of the purified Leydig cells of four hormones (oxytocin, vasopressin, opiates and LHRH) with suggested paracrine roles in the testis. J. Endocrinol. 113: 89, 1987.PubMedCrossRefGoogle Scholar
  62. 62.
    Margioris A.N., Sasaki A., Liotta A.S. Presence and preliminary characterization of immunoreactive dynorphin in human testis. (Abstract). Annual Meeting of The Endocrine Society, 1985: 511.Google Scholar
  63. 63.
    McMurray C.T., Devi L., Calavetta L., Douglass J.O. Regulated expression of prodynorphin gene in the R2C Leydig tumor cell line. Endocrinology 124: 49, 1988.CrossRefGoogle Scholar
  64. 64.
    Chen C., Chang C, Krieger D.T., Bardin C.W. Expression and regulation of proopiomelanocortin-like gene in the ovary and placenta: comparison with the testis. Endocrinology 118: 2382, 1986.PubMedCrossRefGoogle Scholar
  65. 65.
    Kilpatrick D.L., Howell R.D., Noe M., Bailey C.I., Udenfriend S. Expression of preproenkephalin-like mRNA and its peptide products in mammalian testis and ovary. Proc. Natl. Acad. Sci. 82: 7467, 1985.PubMedCentralPubMedCrossRefGoogle Scholar
  66. 66.
    Lim A.T., Lolait S., Barlow J.W., Wai Sum O., Zos I., Toh B.H., Funder J.W. Immunoreactive b-endorphine in sheep ovary. Nature 303: 709, 1983.PubMedCrossRefGoogle Scholar
  67. 67.
    Lolait S.J., Autelitano D.J., Lim A.T.W., Smith A.I., Toh B.H., Funder J.W. Ovarian immunoreactive β-endorphin and estrus-cycle in the rat. Endocrinology 117: 161, 1985.PubMedCrossRefGoogle Scholar
  68. 68.
    Facchineti F., Storchi A.R., Petraglia F., Volpe A., Genazzani A.R. Expression of proopiomelanocortin-related peptides in human follicular fluid. Peptides 9: 1089, 1988.CrossRefGoogle Scholar
  69. 69.
    Sanders S.L., Meiner M.H., Curry Jr T.E. Cellular localization of ovarian proopiomelanocortin messenger RNA during follicular and luteal development in the rat. Mol. Endocrinol. 4: 1311, 1990.PubMedCrossRefGoogle Scholar
  70. 70.
    Chen C.L.C. Expression and regulation of proopiomelanocortin gene and its physiological function in reproductive tissues. In: Martini L., Grong W.F. (Eds.), Frontiers in Neuroendocrinology, Gulyas B.J. Raven Press, Ltd., New York, 1988, vol. 99.Google Scholar
  71. 71.
    Genazzani A.R., Petraglia F., Di Meo G., Santoro V., Facchineti F., Sgre A. Prostaglandin-induced mid-pregnancy abortion increases plasma and amniotic fluid levels of β-lipotropin and β-endorphin. Gynecol. Obstet. Invest. 24: 23, 1987.PubMedCrossRefGoogle Scholar
  72. 72.
    Lemaire S., Vallete A., Chounard L., Dupuis N., Day R., Porthe G., Gros J. Purification and identification of multiple forms of dynorphin in human placenta. Neuropeptides 3: 181, 1983.PubMedCrossRefGoogle Scholar
  73. 73.
    Ahmed M.S., Randall L.W., Sibai B., Dass C., Fridland G., Desiderio D.M., Tolun E. Identification of dynorphin (1–8) in human placenta by mass spectrometry. Life Sci. 40: 2067, 1987.PubMedCrossRefGoogle Scholar
  74. 74.
    Porthe G., Vallete A., Cros J. Kappa opiate binding sites in human placenta. Biochem. Biophys. Res. Com. 101: 1, 1981.PubMedCrossRefGoogle Scholar
  75. 75.
    Valette A., Tafani M., Porthe G., Pontonnier G., Cros J. Placental Kappa binding sites: interaction with dynorphin and its possible implication in hCG secretion. Life Sci. 33: 523, 1983.PubMedCrossRefGoogle Scholar
  76. 76.
    Ahmed M.S. Characterization of solubilized opiate receptors from human placenta. Membr. Biochem. 5: 35, 1983.PubMedCrossRefGoogle Scholar
  77. 77.
    Belisle S., Petit A., Gallo-Payet N., Bellabarda D., Lehoux J.G., Lemaire S. Functional opioid receptor sites in human placentas. J. Clin. Endocrinol. Metab. 66: 283, 1988.PubMedCrossRefGoogle Scholar
  78. 78.
    Makrigiannakis A., Zoumakis E., Margioris A.N., Theodoropoulos P., Stournaras C., Gravanis A. The corticotropin-releasing hormone in normal and tumoral epithelial cells of human endometrium. J. Clin. Endocrinol. Metab. 80: 185, 1995.PubMedGoogle Scholar
  79. 79.
    Mastorakos G., Scopa C.D., Kao L.C, Vryonidou A., Friedman T.C., Kattis D., Phenekos C, Rabin D., Chrousos G.P. Presence of immunoreactive corticotropin-releasing hormone in human endometrium. J. Clin. Endocrinol. Metab. 81: 1046, 1996.PubMedGoogle Scholar
  80. 80.
    Makrigiannakis A., Margioris A.N., LeGoascogne C, Zoumakis E., Nikas G., Stournaras C, Psychoyos A., Gravanis A. Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus. Life Sci. 57: 1869, 1995.PubMedCrossRefGoogle Scholar
  81. 81.
    Zoumakis E., Makrigiannakis A., Margioris A.N., Stournaras C, Gravanis A. Endometrial corticotropin releasing hormone (CRH): its potential autocrine — paracrine actions. Ann. N. Y. Acad. Sci. 1997 In press.Google Scholar
  82. 82.
    Zoumakis E., Makrigiannakis A., Margioris A.N., Stournaras C, Gravanis A. Corticotropin-releasing hormone (CRH) in normal and pregnant uterus: physiological implications. Frontiers in Bioscience 1: 1, 1996.Google Scholar
  83. 83.
    Petraglia F., Tabanelli S., Galassi C., Garuti G.C., Mancini A., Genazzani A., Gurpide E. Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive CRF and CRF mRNA. J. Clin. Endocrinol. Metab. 74: 1427, 1992.PubMedGoogle Scholar
  84. 84.
    Makrigiannakis A., Zoumakis E., Margioris A.N., Stournaras C, Chrousos G.P., Gravanis A. Regulation of the promoter of the human corticotropin-releasing hormone gene in transfected human endometrial cells. Neuroendocrinology 64: 85, 1996.PubMedCrossRefGoogle Scholar
  85. 85.
    Makrigiannakis A., Psychoyos A., Zoumakis E., Margioris A.N., Stournaras C, Gravanis A. Endometrial corticotropin-releasing hormone (CRH): expression, regulation and potential physiological implications. Ann. N. Y. Acad. Sci. 1997. In press.Google Scholar
  86. 86.
    Makrigiannakis A., Margioris A.N., Stournaras C., Gravanis A. Opioid peptides in the female reproductive system. Physiological implications. Biomed. Rev. 4: 71, 1995.CrossRefGoogle Scholar
  87. 87.
    Makrigiannakis A., Margioris A., Markogiannakis E., Stournaras C, Gravanis A. Steroid hormones regulate the release of immunoreactive β-endorphin from Ishikawa human endometrial cell line. J. Clin. Endocrinol. Metab. 75: 584, 1992.PubMedGoogle Scholar
  88. 88.
    Gravanis A., Makrigiannakis A., Stournaras C, Margioris A. Interactions between steroid hormones and endometrial opioid peptides. Ann. N.Y. Acad. Sci. 734: 245, 1994.PubMedCrossRefGoogle Scholar
  89. 89.
    Hatzoglou A., Gravanis A., Margioris AN., Zoumakis E., Castanas E. Identification and characterization of opioid-binding sites present in the Ishikawa human endometrial adenocarcinoma cell line. J. Clin. Endocrinol. Metab. 80: 418, 1995.PubMedGoogle Scholar
  90. 90.
    Karalis K., Sane H., Redwine J., Listwark S., Wilder R., Chrousos G. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254; 421, 1991.PubMedCrossRefGoogle Scholar
  91. 91.
    Markiewitz L., Gravanis A., Schatz F., Holinka C, Gurpide E. Prostaglandin production by human endometrial adenocarcinoma. In: Baulieu E.E., Jacobeli S, McGuire W.L. (Eds.), Endocrinology and Malignancy Parthenon, New Jersey, 1986, p. 420.Google Scholar
  92. 92.
    Simon C, Frances A., Piquette G., Danasouri I., Zurawski G., Dang W., Polan M. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology 134: 521, 1994.PubMedGoogle Scholar
  93. 93.
    Sheth K.V., Roca G.L., Al-Sedairy S., Parhar R., Hamilton G., Al-Abdul Jabbar F. Prediction of successful embryo implantation by measuring interleukin-1-alpha and immunosuppressive factor(s) in preimplantation. Fertil. Steril. 55: 952, 1991.PubMedGoogle Scholar
  94. 94.
    Ferrari A., Petraglia F., Gurpide E. Corticotropin releasing factor decidualizes human endometrial stromal cells in vitro. Interaction with progestin. J. Steroid. Biochem. Mol. Biol. 54: 251, 1995.PubMedCrossRefGoogle Scholar
  95. 95.
    Grunt M., Glaser J., Schmidhuber H., Pauschinger P., Born J. Effects of corticotropin-releasing factor on isolated rat heart activity. Am. J. Physiol. 264: H1124, 1993.PubMedGoogle Scholar
  96. 96.
    Grammatopoulos D., Thompson S., Hillhouse E.W. The human myometrium expresses multiple isoforms of the corticotropin-releasing hormone receptor. J. Clin. Endocrinol. Metab. 80: 2388, 1995.PubMedGoogle Scholar
  97. 97.
    Grammatopoulos D., Stirrat G.M., Williams S.A., Hillhouse E.W. The biological activity of the corticotropin-releasing hormone receptor-adenylate cyclase complex in human myometrium is reduced at the end of pregnancy. J. Clin. Endocrinol. Metab. 81: 745, 1996.PubMedGoogle Scholar
  98. 98.
    Grammatopoulos D., Milton N.G., Hillhouse E.W. The human myometrial CRH receptor: G proteins and second messengers. Mol. Cell. Endocrinol. 99: 245, 1994.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1997

Authors and Affiliations

  • E. Zoumakis
    • 1
  • A. N. Margioris
    • 1
  • A. Makrigiannakis
    • 1
  • C. Stournaras
    • 1
  • A. Gravanis
    • 1
  1. 1.Departments of Pharmacology, Clinical Chemistry, BiochemistryMedical School and University Hospital, University of CreteIraklionGreece

Personalised recommendations